Omega 3 Prescription Drugs Market

Future Market Insights

Key Insight

The omega 3 prescription drugs market is projected to grow from USD 1.6 billion in 2025 to USD 3.6 billion by 2035, at a CAGR of 8.2%. Vascepa will dominate with a 54.0% market share, while cardiovascular diseases will lead the application segment with a 62.0% share.

August 01, 2025

Anurag Sharma

250 Pages

Cite this Report

Omega 3 Prescription Drugs Market

https://www.futuremarketinsights.com/reports/omega-3-prescription-drugs-market

License

Starting at US$ 5000

Buy Now

Summary ToC Companies

Key Players

BASF
GlaxoSmithKline plc (GSK)
KD Pharma Group

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Omega 3 Prescription Drugs Market

Key Players

Similar Industry Reports